Ajai Chari, MD

Ajai Chari, MD, discusses the biggest challenge in treating patients with multiple myeloma.

Ajai Chari, MD, discusses the rationale for using combination therapy in patients with multiple myeloma. 

Ajai Chari, MD, associate professor of medicine at the Mount Sinai School of Medicine, advises on the best way to choose treatment regimens for patients with multiple myeloma. Since 9 different drugs have been approved after many phase III trials, a community physician may be overwhelmed by this surplus of options, Chari says.

Ajai Chari, MD, associate professor, Mount Sinai Hospital, discusses some of the recent clinical trial evidence for early relapsed multiple myeloma and how it can be put into practice.